Cancer clinical trial recruitment: The emerging role and perspectives of clinical research associates and data managers

Cancer

Volumn 95, Issue 7, 2002, Pages 1397-1400

  Tattersall, Martin ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER RESEARCH; CLINICAL RESEARCH; DATA ANALYSIS; HUMAN; MANAGER; PATIENT SELECTION; PERSONNEL MANAGEMENT; POLICY; PRIORITY JOURNAL; REVIEW;

CLINICAL TRIALS; DECISION MAKING; ETHICS, MEDICAL; HUMANS; NEOPLASMS; PATIENT SELECTION; RESEARCH DESIGN;

EID: 0036786392     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.10863     Document Type: Review

References (18)

1. Peto R, Baigent C. Trials: the next 50 years. BMJ. 1998;317:1170-1171.
2. Rettig RA. The industrialization of clinical research. Health Affairs. 2000;19:129-146.
3. Davidoff F, DeAngelis CD, Drazen JM, et al. Sponsorship, authorship, and accountability. Lancet. 2001;358:854-856.
4. Kelch RP. Maintaining the public trust in clinical research. N Engl J Med. 2002;346:285-287.
5. Grossman SA, Piantadosi S, Covahey C. Are informed consent forms that describe clinical oncology research protocols readable by most patients and their families? J Clin Oncol. 1994;12:2211-2215.
6. Edwards SJL, Lilford RJ, Hewison J. The ethics of randomised controlled trials from the perspectives of patients, the public, and healthcare professionals. BMJ. 1998;317:1209-1212.
7. Llewellyn-Thomas HA, Thiel EC, Semin WC, et al. Presenting clinical trial information: a comparison of methods. Patient Educ Couns. 1995;25:97-107.
8. Ellis PM, Butow PN, Tattersall MHN, et al. Randomized clinical trials in oncology: understanding and attitudes predict willingness to participate. J Clin Oncol. 2001;19:3554-361.
9. Joffe S, Cook EF, Cleary PD, Clark JW, Weeks JC. Quality of informed consent: a new measure of understanding among research subjects. J Natl Cancer Inst. 2001;93:139-147.
10. Joffe S, Cook EF, Cleary PD, et al. Quality of informed consent in cancer clinical trials: a cross-sectional survey. Lancet. 2001;358:172-177.
11. Wright JR, Ellis PM, Crooks D, et al. Factors influencing recruitment to phase III studies in oncology: the perspective of the clinical research associate. Cancer. 2002;95:1584-91.
12. Grunfeld E, Zitzelsberger L, Coristine M, Aspelund F. Barriers and facilitators to enrollment in cancer clinical trials: qualitative study of the perspectives of clinical research associates. Cancer. 2002;95:1577-83.
13. Albrecht TL, Blanchard C, Ruckdeschel JC, Coovert M, Strongbow R. Strategic physician communication and oncology clinical trials. J Clin Oncol. 1999;17:3324-3332.
14. Jenkins VA, Fallowfield LJ, Souhami A, Sawtell M. How do doctors explain randomised clinical trials to their patients? Eur J Cancer. 1999;35:1187-1193.
15. Butow PN, Brown RF, Tattersall MHN. Ethics of clinical trials. N Engl J Med. 2000;342:978.
16. Verheggen FWSM, Jonkers R, Kok G. Patients' perceptions on informed consent and the quality of information disclosure in clinical trials. Patient Educ Couns. 1996;29:137-153.
17. Fleissig A, Jenkins V, Fallowfield L. Results of an intervention study to improve communication about randomised clinical trials of cancer therapy. Eur J Cancer. 2001;37:322-331.
18. Sawka CA, Pritchard KI. Can improved communication increase patient participation in randomised clinical trials. Eur J Cancer. 2001;37:297-299.